First subject dosed with company’s SPL028 – a proprietary deuterated DMT candidate More: Small Pharma begins phase 1 mental health therapy trial Source: News
read moreAfter J&J’s Texas two-step stumble, another talc plaintiff heads to trial: report fkansteiner Wed, 02/15/2023 – 11:10 More: After J&J's Texas two-step stumble, another talc plaintiff heads to trial: report Source: fierce
read more10 years after selling Bausch + Lomb, controversial dealmaker Saunders is back as CEO kdunleavy Wed, 02/15/2023 – 10:43 More: 10 years after selling Bausch + Lomb, controversial dealmaker Saunders is back as CEO Source: fierce
read moreBiogen chairman to step down as new CEO walks thin line with Alzheimer’s launch Leqembi aliu Wed, 02/15/2023 – 10:21 More: Biogen chairman to step down as new CEO walks thin line with Alzheimer's launch Leqembi Source: fierce
read moreGSK was warned repeatedly about Zantac impurity but played down risks: Bloomberg esagonowsky Wed, 02/15/2023 – 09:02 More: GSK was warned repeatedly about Zantac impurity but played down risks: Bloomberg Source: fierce
read moreBavarian Nordic scoops up Emergent’s travel vaccines, manufacturing site in deal worth up to $380M fkansteiner Wed, 02/15/2023 – 08:59 More: Bavarian Nordic scoops up Emergent's travel vaccines, manufacturing site in deal worth up to 0M Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals